Glancy Prongay Wolke & Rotter LLP Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors

Stock Information for RxSight Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About RxSight Inc.

RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
Law Offices of Howard G. Smith Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors
The Law Offices of Frank R. Cruz Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.